Lifeist Announces Results of Annual General and Special Meeting of Shareholders
20 Marzo 2024 - 12:00PM
Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV:
LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech
company that leverages advancements in science and technology to
build breakthrough ventures that transform human wellness, today
announced the results of the Company’s Annual General and Special
Meeting of the shareholders held on March 14, 2024 (the “AGSM”).
A total of 191,161,948 common shares were
represented in person or by proxy at the AGSM, representing 33.44%
of the votes of all outstanding common shares of the Company as at
the record date. Shareholders voted for the items of business
brought before them at the AGSM as follows:
- The four
nominees to the Company's Board of Directors, namely Meni
Morim, Laurens Feenstra, Branden Spikes, and John Sinclair, were
elected for the ensuing year.
- Clearhouse LLP,
Chartered Public Accountants were appointed as the Company's
auditor to hold office until the next annual meeting of
shareholders or until its successor is duly appointed, at a
remuneration to be fixed by the Board.
- The yearly
shareholder approval required by TSXV rules for the continued use
of the Company’s Amended and Restated Stock Option Plan was
obtained.
- Shareholders
also passed an ordinary resolution to approve a proposed
consolidation of the issued and outstanding common shares of the
Company on the basis of a consolidation ratio to be selected by the
Board, within a range of between five (5) pre-consolidation common
shares for one (1) post-consolidation common share and twenty (20)
pre-consolidation common shares for one (1) post-consolidation
common share.
- The special
resolution for the proposed sale of the Company’s CannMart Group
did not meet a super majority and therefore was not approved.
It is important to understand that the proposal
to sell the CannMart Group was the result of careful consideration
by the Company’s Board of Director with input and advice from
advisors and was aimed at securing the near- and long-term
viability and success of Lifeist for the benefit of all
shareholders.
The regulatory framework under which Canadian
public cannabis companies operate has proven to be prohibitively
expensive in terms of being able to turn a profit. Rather than
representing discrete overhead costs (one set for being a public
reporting company, the other set for being a licensed cannabis
company), the regulatory burdens are significantly magnified by
having to meet both sets of requirements simultaneously. This has
been compounded by the fact that all public company costs such as
audit and D&O insurance are significantly higher for cannabis
companies compared to companies of similar size in other
sectors.
This experience has not been unique to Lifeist
or CannMart: most Canadian public cannabis company, from the
largest to the smallest, from generalists growing stadium-sized
crops to specialists focused on extracts, distillates, beverages,
and exotics, have been unable to turn a consistent profit. As a
result, the entire public sector has been in a long and continuous
bear market, with punishing capital rotations out of every stock in
the category. The proposed sale of the CannMart Group was intended
to divest Lifeist of the continued negative cash flow that the
cannabis business has cost shareholders since inception.
The Board of Directors respects the decision of
shareholders and shall make every possible effort and explore every
alternative avenue to adapt and restructure the CannMart Group
toward future success.
Concurrently, Lifeist will continue to direct
increased focus toward its Mikra and Aussie Vapes businesses and
will provide more information about those developments in the near
future. Initiatives presently underway at Lifeist’s operating
subsidiaries hold great promise for the realization of shareholder
value, and we are dedicated to executing aggressively on that
immediate strategy.
About Lifeist Wellness Inc.
Sitting at the forefront of the post-pandemic
wellness revolution, Lifeist leverages advancements in science and
technology to build breakthrough companies that transform human
wellness. Portfolio business units include: Mikra, a biosciences
and consumer wellness company developing and selling innovative
products for cellular health; CannMart, which operates a B2B
wholesale distribution business facilitating recreational cannabis
sales to Canadian provincial government control boards including
for CannMart Labs, a BHO extraction facility producing high margin
cannabis 2.0 products; and Australian Vapes, one of Australia’s
largest online retailers of vaporizers and accessories.
Information on Lifeist and its businesses can be
accessed through the links below:
www.lifeist.com https://wearemikra.com/
https://cannmart.com www.australianvaporizers.com.au
Contact: Meni MorimCEOLifeist
Wellness Inc.Ph: 647-362-0390 Email: ir@lifeist.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release or has in any way approved
or disapproved of the contents of this press release.
Forward Looking Information
This news release contains “forward-looking
information” within the meaning of applicable securities laws. All
statements contained herein that are not historical in nature
contain forward-looking information. Forward-looking information
can be identified by words or phrases such as “may”, “expect”,
“likely”, “should”, “would”, “plan”, “anticipate”, “intend”,
“potential”, “proposed”, “estimate”, “believe” or the negative of
these terms, or other similar words, expressions and grammatical
variations thereof, or statements that certain events or conditions
“may” or “will” happen.
The forward-looking information contained
herein, including, without limitation, statements related to a
restructuring or other alternative arrangement with respect to the
CannMart Group are made as of the date of this news release and are
based on assumptions management believed to be reasonable at the
time such statements were made, including without limitation,
appropriate economic alternatives can be found to adapt and
restructure CannMart, and Mikra and Aussie Vapes can become
profitable in the short-term, as well as other considerations that
are believed to be appropriate in the circumstances. While we
consider these assumptions to be reasonable based on information
currently available to management, there is no assurance that such
expectations will prove to be correct. By its nature,
forward-looking information is subject to inherent risks and
uncertainties that may be general or specific and which give rise
to the possibility that expectations, forecasts, predictions,
projections or conclusions will not prove to be accurate, that
assumptions may not be correct, and that objectives, strategic
goals and priorities will not be achieved. A variety of factors,
including known and unknown risks, many of which are beyond our
control, could cause actual results to differ materially from the
forward-looking information in this news release. Such factors
include, without limitation: the inability of the Company to
complete a feasible and economic restructuring of the CannMart
Group, in a timely manner, if at all, the Company’s failure to
develop its businesses as anticipated and to realize on the
anticipated benefits from its increased focus on its Mikra and
Aussie Vapes businesses unanticipated changes to current
regulations that would adversely impact its businesses, unforeseen
developments that would delay its businesses the ability to sell
newly developed products, the risk that the expected demand for
products in general and those of its businesses in particular does
not develop as anticipated and risks relating to the Company’s
ability to execute its business strategy and the benefits
realizable therefrom. Additional risk factors can also be found in
the Company’s current MD&A filed under the Company’s SEDAR+
profile at www.sedarplus.ca. Readers are cautioned not to put undue
reliance on forward-looking information. The Company undertakes no
obligation to update or revise any forward-looking information,
whether as a result of new information, future events or otherwise,
except as required by applicable law. Forward-looking statements
contained in this news release are expressly qualified by this
cautionary statement.
Source: Lifeist Wellness Inc.
Grafico Azioni Lifeist Wellness (TSXV:LFST)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Lifeist Wellness (TSXV:LFST)
Storico
Da Dic 2023 a Dic 2024